drugset / Trial / NCT05644769
Chymase Angiotensin-(1-12) Axis In Hypertensive Disease
Phase 4
Unknown
10 enrolled
Trinity Hypertension & Metabolic Research Institute
Wake Forest University Health Sciences · collab
RandomizedCrossoverOpen-labelTreatment
Summary
Determine the presence of the human sequence of Angiotensin-(1-12) in plasma of ten untreated hypertensive subjects and after 4 week with Lisinopril 40 mg every day. Determine the blood pressure reduction with Lisinopril 40mg.
Timeline
- Start
- 2022-11-15
- Primary completion
- 2023-03-31
- Completion
- 2023-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | LISINOPRIL ANHYDROUS | Small molecule | 40 mg | — |